ATXI Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 19:39):

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting...

Stats
Dzisiejszy wolumen	247 547
Średni wolumen	34 351.00
Kapitalizacja rynkowa	3.04M
EPS	$0 ( 2024-03-28 )
Następna data zysków	( $-9.00 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0700
ATR14	$0.0570 (1.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-16	Fortress Biotech, Inc.	Buy	413 507	COMMON STOCK, PAR VALUE $0.0001
2024-01-02	Fortress Biotech, Inc.	Buy	2 101 496	COMMON STOCK, PAR VALUE $0.0001
2023-12-11	Davidow Robert L	Sell	264 000	Common Stock
2023-12-11	Davidow Robert L	Sell	126 000	Common Stock
2023-12-11	Davidow Robert L	Sell	128 000	Common Stock

INSIDER POWER
72.66
Last 83 transactions
Buy: 6 766 707 \| Sell: 1 021 576

Wolumen Korelacja

Długi: 0.32 (neutral)

Krótki: 0.89 (strong)

Signal:(44.065) Same movement expected

Avenue Therapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
GETVV	0.801

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Avenue Therapeutics Inc Korelacja - Waluta/Towar

0.28
( neutral )

0.22
( neutral )

0.00
( neutral )

-0.02
( neutral )

0.28
( neutral )

-0.32
( neutral )

Avenue Therapeutics Inc Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-73.48

FY	2023
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-73.48

FY	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$0.940

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-3.39

Financial Reports:

No articles found.

Avenue Therapeutics Inc

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.